NO20002164L - Kombinasjon av en aldose reduktase inhibitor og en glycogen fosforylase inhibitor - Google Patents
Kombinasjon av en aldose reduktase inhibitor og en glycogen fosforylase inhibitorInfo
- Publication number
- NO20002164L NO20002164L NO20002164A NO20002164A NO20002164L NO 20002164 L NO20002164 L NO 20002164L NO 20002164 A NO20002164 A NO 20002164A NO 20002164 A NO20002164 A NO 20002164A NO 20002164 L NO20002164 L NO 20002164L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitor
- combination
- aldose reductase
- glycogen phosphorylase
- reductase inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Superheterodyne Receivers (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Noise Elimination (AREA)
- Enzymes And Modification Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6636597P | 1997-11-21 | 1997-11-21 | |
PCT/IB1998/001752 WO1999026659A1 (en) | 1997-11-21 | 1998-11-02 | Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20002164D0 NO20002164D0 (no) | 2000-04-27 |
NO20002164L true NO20002164L (no) | 2000-07-19 |
Family
ID=22069038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20002164A NO20002164L (no) | 1997-11-21 | 2000-04-27 | Kombinasjon av en aldose reduktase inhibitor og en glycogen fosforylase inhibitor |
Country Status (38)
Country | Link |
---|---|
EP (1) | EP1032424B9 (ru) |
JP (1) | JP2002504478A (ru) |
KR (2) | KR20010032304A (ru) |
CN (1) | CN1279617A (ru) |
AP (1) | AP911A (ru) |
AR (1) | AR016423A1 (ru) |
AT (1) | ATE205403T1 (ru) |
AU (1) | AU733304B2 (ru) |
BG (1) | BG104435A (ru) |
BR (1) | BR9814698A (ru) |
CA (1) | CA2310069A1 (ru) |
DE (1) | DE69801680T2 (ru) |
DK (1) | DK1032424T3 (ru) |
DZ (1) | DZ2656A1 (ru) |
EA (1) | EA002365B1 (ru) |
ES (1) | ES2161548T3 (ru) |
GR (1) | GR3037071T3 (ru) |
GT (1) | GT199800166A (ru) |
HR (1) | HRP20000327A2 (ru) |
HU (1) | HUP0100272A3 (ru) |
ID (1) | ID24524A (ru) |
IL (1) | IL135713A0 (ru) |
IS (1) | IS5453A (ru) |
MA (1) | MA26568A1 (ru) |
NO (1) | NO20002164L (ru) |
OA (1) | OA11379A (ru) |
PA (1) | PA8462301A1 (ru) |
PE (1) | PE135399A1 (ru) |
PL (1) | PL340643A1 (ru) |
PT (1) | PT1032424E (ru) |
SK (1) | SK7222000A3 (ru) |
TN (1) | TNSN98211A1 (ru) |
TR (1) | TR200001451T2 (ru) |
UA (1) | UA57811C2 (ru) |
UY (1) | UY25258A1 (ru) |
WO (1) | WO1999026659A1 (ru) |
YU (1) | YU30700A (ru) |
ZA (1) | ZA9810636B (ru) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002536410A (ja) * | 1999-02-12 | 2002-10-29 | ノボ ノルディスク アクティーゼルスカブ | 肥満の治療又は予防もしくは食欲の調節を目的とした薬学的組成物の製造におけるピロリジン誘導体の使用 |
CN1977842A (zh) | 2000-01-21 | 2007-06-13 | 诺瓦提斯公司 | 含有二肽基肽酶-iv抑制剂和抗糖尿病药物的联合形式 |
CO5271699A1 (es) | 2000-01-24 | 2003-04-30 | Pfizer Prod Inc | Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa |
US6570013B2 (en) | 2000-02-16 | 2003-05-27 | Pfizer Inc | Salts of zopolrestat |
US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
IL144507A0 (en) * | 2000-07-31 | 2002-05-23 | Pfizer Prod Inc | Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
WO2002098429A1 (en) * | 2001-06-07 | 2002-12-12 | Pfizer Products Inc. | Ethanolamine, diethanolamine or triethanolamine salt of zopolrestat |
GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205162D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205176D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205175D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205170D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205166D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
US7057046B2 (en) | 2002-05-20 | 2006-06-06 | Bristol-Myers Squibb Company | Lactam glycogen phosphorylase inhibitors and method of use |
CA2392486A1 (en) | 2002-07-05 | 2002-12-08 | Duchesnay Inc. | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
US7098235B2 (en) | 2002-11-14 | 2006-08-29 | Bristol-Myers Squibb Co. | Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds |
BRPI0416444B8 (pt) | 2003-11-12 | 2021-05-25 | Chiesi Farm Spa | composto de ácido borônico heterocíclico, composição farmacêutica, e, combinação farmacêutica compreendendo o mesmo |
US7317109B2 (en) | 2003-11-12 | 2008-01-08 | Phenomix Corporation | Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
US7767828B2 (en) | 2003-11-12 | 2010-08-03 | Phenomix Corporation | Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
US7576121B2 (en) | 2003-11-12 | 2009-08-18 | Phenomix Corporation | Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
CA2573848A1 (en) | 2004-07-12 | 2006-02-16 | Phenomix Corporation | Constrained cyano compounds |
US7214704B2 (en) | 2004-11-15 | 2007-05-08 | Bristol-Myers Squibb Company | 2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
WO2006055463A2 (en) | 2004-11-15 | 2006-05-26 | Bristol-Myers Squibb Company | 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
WO2006055435A1 (en) | 2004-11-15 | 2006-05-26 | Bristol-Myers Squibb Company | 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors |
WO2006055462A1 (en) | 2004-11-15 | 2006-05-26 | Bristol-Myers Squibb Company | 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
WO2006113261A2 (en) | 2005-04-14 | 2006-10-26 | Bristol-Myers Squibb Company | Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
US7825139B2 (en) | 2005-05-25 | 2010-11-02 | Forest Laboratories Holdings Limited (BM) | Compounds and methods for selective inhibition of dipeptidyl peptidase-IV |
ES2445180T5 (es) | 2005-09-14 | 2022-02-01 | Takeda Pharmaceuticals Co | Administración de inhibidores de dipeptidil peptidasa |
US8318941B2 (en) | 2006-07-06 | 2012-11-27 | Bristol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
US7727978B2 (en) | 2006-08-24 | 2010-06-01 | Bristol-Myers Squibb Company | Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors |
CN101687873A (zh) | 2007-04-17 | 2010-03-31 | 百时美施贵宝公司 | 具有稠合杂环的11β-羟基类固醇Ⅰ型脱氢酶抑制剂 |
EP2144902B1 (en) | 2007-05-04 | 2012-05-16 | Bristol-Myers Squibb Company | [6,6]and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
US8093257B2 (en) | 2007-05-04 | 2012-01-10 | Bristol-Myers Squibb Company | [6,5]-bicyclic GPR119 G protein-coupled receptor agonists |
CA2693439A1 (en) | 2007-07-17 | 2009-01-22 | Bristol-Myers Squibb Company | Pyridone gpr119 g protein-coupled receptor agonists |
TW201006821A (en) | 2008-07-16 | 2010-02-16 | Bristol Myers Squibb Co | Pyridone and pyridazone analogues as GPR119 modulators |
WO2011041293A1 (en) | 2009-09-30 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors |
WO2011097079A1 (en) | 2010-02-03 | 2011-08-11 | Takeda Pharmaceutical Company Limited | Apoptosis signal-regulating kinase 1 inhibitors |
WO2011127106A1 (en) | 2010-04-08 | 2011-10-13 | Bristol-Myers Squibb Company | Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators |
ES2559209T3 (es) | 2010-04-14 | 2016-02-11 | Bristol-Myers Squibb Company | Nuevos activadores de la glucocinasa y métodos de uso de los mismos |
EA201270778A1 (ru) | 2010-05-06 | 2013-04-30 | Бристол-Майерс Сквибб Компани | Бициклические гетероарильные аналоги в качестве модуляторов рецептора gpr119 |
US8729084B2 (en) | 2010-05-06 | 2014-05-20 | Bristol-Myers Squibb Company | Benzofuranyl analogues as GPR119 modulators |
ES2555927T3 (es) | 2011-01-20 | 2016-01-11 | Bionevia Pharmaceuticals Inc. | Composiciones de liberación modificada de epalrestat o un derivado del mismo y métodos para el uso de las mismas |
EP2850073B1 (en) | 2012-05-16 | 2017-07-19 | Bristol-Myers Squibb Company | Pyrimidinylpiperidinyloxypyridone analogues as gpr119 modulators |
US9580422B2 (en) | 2013-10-22 | 2017-02-28 | Bristol-Myers Squibb Company | Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
MA45714A (fr) | 2016-07-22 | 2019-05-29 | Bristol Myers Squibb Co | Activateurs de glucokinase et leurs procédés d'utilisation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4825448A (en) * | 1986-08-07 | 1989-04-25 | International Mobile Machines Corporation | Subscriber unit for wireless digital telephone system |
EP0343273B1 (de) * | 1988-05-27 | 1994-04-27 | Deutsche ITT Industries GmbH | Korrekturschaltung für ein digitales Quadratur-Signalpaar |
US5391551A (en) * | 1993-05-10 | 1995-02-21 | Pfizer Inc. | Method of lowering blood lipid levels |
JP3314938B2 (ja) * | 1995-06-06 | 2002-08-19 | ファイザー・インコーポレーテッド | グリコーゲンホスホリラーゼ抑制剤としての置換されたn−(インドール−2−カルボニル)−グリシンアミド類および誘導体 |
MX9709874A (es) * | 1995-06-06 | 1998-03-31 | Pfizer | N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN. |
-
1998
- 1998-02-11 UA UA2000052869A patent/UA57811C2/ru unknown
- 1998-10-27 GT GT199800166A patent/GT199800166A/es unknown
- 1998-10-28 PA PA19988462301A patent/PA8462301A1/es unknown
- 1998-11-02 CA CA002310069A patent/CA2310069A1/en not_active Abandoned
- 1998-11-02 EA EA200000433A patent/EA002365B1/ru not_active IP Right Cessation
- 1998-11-02 HU HU0100272A patent/HUP0100272A3/hu unknown
- 1998-11-02 ID IDW20000958A patent/ID24524A/id unknown
- 1998-11-02 AU AU95558/98A patent/AU733304B2/en not_active Ceased
- 1998-11-02 SK SK722-2000A patent/SK7222000A3/sk unknown
- 1998-11-02 AT AT98949193T patent/ATE205403T1/de not_active IP Right Cessation
- 1998-11-02 JP JP2000521860A patent/JP2002504478A/ja active Pending
- 1998-11-02 PL PL98340643A patent/PL340643A1/xx unknown
- 1998-11-02 PT PT81300054T patent/PT1032424E/pt unknown
- 1998-11-02 KR KR1020007005514A patent/KR20010032304A/ko not_active Application Discontinuation
- 1998-11-02 WO PCT/IB1998/001752 patent/WO1999026659A1/en not_active Application Discontinuation
- 1998-11-02 DK DK98949193T patent/DK1032424T3/da active
- 1998-11-02 IL IL13571398A patent/IL135713A0/xx unknown
- 1998-11-02 ES ES98949193T patent/ES2161548T3/es not_active Expired - Lifetime
- 1998-11-02 DE DE69801680T patent/DE69801680T2/de not_active Expired - Fee Related
- 1998-11-02 EP EP98949193A patent/EP1032424B9/en not_active Expired - Lifetime
- 1998-11-02 BR BR9814698-0A patent/BR9814698A/pt not_active IP Right Cessation
- 1998-11-02 TR TR2000/01451T patent/TR200001451T2/xx unknown
- 1998-11-02 CN CN98811329A patent/CN1279617A/zh active Pending
- 1998-11-02 YU YU30700A patent/YU30700A/sh unknown
- 1998-11-16 PE PE1998001113A patent/PE135399A1/es not_active Application Discontinuation
- 1998-11-18 DZ DZ980266A patent/DZ2656A1/xx active
- 1998-11-18 TN TNTNSN98211A patent/TNSN98211A1/fr unknown
- 1998-11-19 AR ARP980105883A patent/AR016423A1/es not_active Application Discontinuation
- 1998-11-19 UY UY25258A patent/UY25258A1/es not_active Application Discontinuation
- 1998-11-19 AP APAP/P/1998/001401A patent/AP911A/en active
- 1998-11-19 MA MA25356A patent/MA26568A1/fr unknown
- 1998-11-20 ZA ZA9810636A patent/ZA9810636B/xx unknown
-
1999
- 1999-05-07 KR KR1020007013394A patent/KR100661214B1/ko not_active IP Right Cessation
-
2000
- 2000-04-14 IS IS5453A patent/IS5453A/is unknown
- 2000-04-27 NO NO20002164A patent/NO20002164L/no not_active Application Discontinuation
- 2000-05-12 OA OA1200000137A patent/OA11379A/en unknown
- 2000-05-15 BG BG104435A patent/BG104435A/bg unknown
- 2000-05-19 HR HR20000327A patent/HRP20000327A2/hr not_active Application Discontinuation
-
2001
- 2001-10-30 GR GR20010401943T patent/GR3037071T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20002164D0 (no) | Kombinasjon av en aldose reduktase inhibitor og en glycogen fosforylase inhibitor | |
PT946323E (pt) | Pos de niobio e condensadores eletroliticos de niobio | |
EP1009415A4 (en) | INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES | |
DK1454907T3 (da) | Quninazolin og pyridopyrmidin-derivativer | |
ID29434A (id) | Kombinasi-kombinasi herbisida dan pengaman | |
DK0915880T3 (da) | Azolotriaziner og pyrimidiner | |
DE69725256D1 (de) | Plasmavergasung und -verglasung von Aschen | |
NO20001926D0 (no) | iso-CBI- og iso-CI-analoger av CC-1065 og duokarmyciner | |
NO20000996L (no) | Kombinasjonsterapi omfattende atorvastatin og et antihypertensivt middel | |
IL137252A0 (en) | Combined percussion and trepan laser drilling | |
DE69820397D1 (de) | Ätzmittel und ihre Verwendung | |
NO20003488D0 (no) | Homopolymerer og kopolymerer av etylen | |
FI953551A0 (fi) | Näppäimistö ja näppäin | |
NO994441D0 (no) | Ekstraksjon og anvendelse av VNTR-alleler | |
NO20015087D0 (no) | Kombinasjon av et kammer og et stempel | |
AU5374098A (en) | Combinatorial libraries of imidazol-pyrido-indoles and imidazol-pyrido-benzothiophene derivatives | |
DK0677733T3 (da) | Gaslazer og gasdetektion dermed | |
PL341335A1 (en) | Combination of ace and mmp inhibitors | |
GB9827391D0 (en) | Aldose reductase inhibitors and pharmaceutical compositions | |
NO980107D0 (no) | Detektering og biologisk nedbrytning av eksplosiver | |
NO20011703D0 (no) | Kondensator av ikke-brennbar og uhellsforhindrende type | |
NO981101D0 (no) | Stabilisering og sementering av laterale borehull | |
FI973731A0 (fi) | Temperaturkompensation i elektroniska anordningar | |
NO20001398L (no) | Kombinasjon av en 5-HT1A antagonist og en selektiv h5-HT1B antagonist eller partial antagonist | |
DE29601388U1 (de) | Wärme- und Schallschutzfenster |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |